Other studies have proposed the use of TGF-β1, AGT, and EGFR mRNA levels in urine samples of KTP as timely indicators of chronic allograft nephropathy (CAN) development (Mas et al., 2007a; Mas et al., 2007b). The gene discussed is TGFB1; the disease is Crouzon syndrome-acanthosis nigricans syndrome.